Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00678249 · ClinicalTrials.gov registry record · NA

Pivotal Study for the FLAIR Endovascular Stent Graft

A NA study, sponsored by C. R. Bard.

Completed
Registry status
NA
Development phase
227
Enrollment target

NCT00678249: Completed NA study, sponsored by C. R. Bard.

NCT00678249 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 227 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00678249, a NA study, has completed, sponsored by C. R. Bard.

COMPLETED
Registry status
NA
Development phase
227 participants
Enrollment target

Study Summary

This study compared the FLAIR™ Endovascular Stent Graft to balloon angioplasty in patients with stenoses at the venous anastomosis of a synthetic AV access graft.

Primary Outcome

TAPP was defined as patency (open to blood flow) after the study index procedure until reintervention in the treatment area (within 5 mm proximal or 5 mm distal to the study device or index balloon angioplasty treatment area), or thrombotic occlusion that involved the treatment area.

Interventions

  • DEVICE FLAIR Endovascular Stent Graft
  • PROCEDURE PTA

Trial Details

FieldValue
Enrollment Target 227 participants
Start Date 2001-01
Est. Completion 2004-06
Phase NA
C. R. Bard

75 total trials

What the finished NCT00678249 record still lists

NCT00678249 is an interventional study that assigns participants to a tested intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which FLAIR Endovascular Stent Graft is the first listed.

NCT00678249 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00678249 about?

NCT00678249 is a clinical study titled "Pivotal Study for the FLAIR Endovascular Stent Graft". This study compared the FLAIR™ Endovascular Stent Graft to balloon angioplasty in patients with stenoses at the venous anastomosis of a synthetic AV access graft.

What is the current status of trial NCT00678249?

This trial is currently completed. It is a NA study. The enrollment target is 227 participants. The study started on 2001-01. Estimated completion is 2004-06.

What interventions are being tested in trial NCT00678249?

The interventions under investigation include: FLAIR Endovascular Stent Graft (DEVICE), PTA (PROCEDURE).

Who is sponsoring clinical trial NCT00678249?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00678249's enrollment target sits among peer trials

227 471st of 2000 higher than 1,530 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04751409 · 227 participants · Phase 2

    Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

  • NCT05742360 · 227 participants

    Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

  • NCT05890352 · 227 participants · Phase 2

    Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • NCT05107908 · 228 participants · NA

    Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00678249, the US trial registry maintained by the National Library of Medicine. NCT00678249 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.